Viemed Healthcare (VMD) Income from Continuing Operations (2018 - 2026)
Viemed Healthcare's (VMD) quarterly Income from Continuing Operations came in at 2713000.0 in Q1 2026, little changed YoY from 2710000.0 in Q1 2025, and down 53.35% on a QoQ basis from 5816000.0 in Q4 2025.
Viemed Healthcare (VMD) Income from Continuing Operations (2018 - 2026) Analysis & Trends
Viemed Healthcare (VMD) has 9 years of Income from Continuing Operations data on file, last reported at 2713000.0 in Q1 2026.
- Quarterly Income from Continuing Operations changed 0.11% year-over-year to 2713000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 15379000.0 (up 22.87% YoY) and the FY2025 annual result came in at 15376000.0, up 34.77% from the prior year.
- Income from Continuing Operations eased to 2713000.0 in Q1 2026, from 5816000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 5816000.0 in Q4 2025 to a low of 967000.0 in Q2 2022.
- A 5-year average of 2703705.88 and a median of 2710000.0 in 2025 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations sank 41.03% — and 2023, when it surged 176.68%.
- Tracing VMD's Income from Continuing Operations over 5 years: stood at 2438000.0 in 2022, then soared by 42.62% to 3477000.0 in 2023, then gained by 27.24% to 4424000.0 in 2024, then soared by 31.46% to 5816000.0 in 2025, then slumped by 53.35% to 2713000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 2713000.0 (Q1 2026), 5816000.0 (Q4 2025), and 3600000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Viemed Healthcare | 329.48 Mn | 318.80 Mn | 45.05 Mn | 2.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.90 Mn |
| Mar 31, 2026 | 2.71 Mn |
| Dec 31, 2025 | 5.82 Mn |
| Sep 30, 2025 | 3.60 Mn |
| Jun 30, 2025 | 3.25 Mn |
| Mar 31, 2025 | 2.71 Mn |
| Dec 31, 2024 | 4.42 Mn |
| Sep 30, 2024 | 3.91 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Mar 31, 2024 | 1.60 Mn |
| Dec 31, 2023 | 3.48 Mn |
| Sep 30, 2023 | 2.92 Mn |
| Jun 30, 2023 | 2.33 Mn |
| Mar 31, 2023 | 1.52 Mn |
| Dec 31, 2022 | 2.44 Mn |
| Sep 30, 2022 | 1.06 Mn |
| Jun 30, 2022 | 967,000.00 |
| Mar 31, 2022 | 1.76 Mn |
| Dec 31, 2021 | 4.09 Mn |
| Sep 30, 2021 | 1.79 Mn |